Search

Your search keyword '"Palafox-Sánchez CA"' showing total 222 results

Search Constraints

Start Over You searched for: "Palafox-Sánchez CA" Remove constraint "Palafox-Sánchez CA"
222 results on '"Palafox-Sánchez CA"'

Search Results

51. The functional class evaluated in rheumatoid arthritis is associated with soluble TGF-β1 serum levels but not with G915C (Arg25Pro) TGF-β1 polymorphism.

52. Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis.

53. Plasminogen activator inhibitor-1 polymorphisms (-844 G>A and HindIII C>G) in systemic lupus erythematosus: association with clinical variables.

54. Autoantibodies to a miRNA-binding protein Argonaute2 (Su antigen) in patients with hepatitis C virus infection.

55. High prevalence of autoantibodies to RNA helicase A in Mexican patients with systemic lupus erythematosus.

56. Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis.

57. A functional Ser(413)/Ser(413) PAI-2 polymorphism is associated with susceptibility and damage index score in systemic lupus erythematosus.

58. Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies.

59. Expression of ICAM1 and VCAM1 serum levels in rheumatoid arthritis clinical activity. Association with genetic polymorphisms.

61. Advances in cellular and molecular pathways of salivary gland damage in Sjögren's syndrome.

62. Evaluating the docetaxel effect in an animal model of polyarthritis.

63. Evaluation of changes in root canal length and accuracy of the electronic apex locator during different stages of endodontic treatment and retreatment.

66. BAFF overexpression in triple-negative breast cancer promotes tumor growth by inducing IL-10-secreting regulatory B cells that suppress anti-tumor T cell responses.

67. Graves' disease and systemic lupus erythematosus: a Mendelian randomization study.

68. Anti–Peptidylarginine Deiminase 4 Autoantibodies and Disease Duration as Predictors of Treatment Response in Rheumatoid Arthritis.

70. Residual dentin thickness of root canal transportation by various metallurgical rotary systems: An in vitro study.

71. Analysis of IL-1β, TGF-β, IL-5, ACE, PTPN22 gene polymorphisms, and gene expression levels in Turkish children with IgA vasculitis.

72. Immune checkpoints in rheumatoid arthritis: progress and promise.

73. Associations between TNFSF13B polymorphisms and primary Sjögren's syndrome susceptibility in primary Sjögren's syndrome patients: A meta‐analysis.

74. Single nucleotide polymorphisms in cytokine genes and their association with primary Sjögren's syndrome in Saudi patients: A cross-sectional study.

75. Efficacy and safety of telitacicept therapy in systemic lupus erythematosus with hematological involvement.

76. The causal relationship between multiple autoimmune diseases and nasal polyps.

77. Analysis of obtaining apical patency indexes during endodontic treatments considering gender, age, pulpoperiradicular diagnosis and canal/tooth—A clinical study.

78. An immuno-lipidomic signature revealed by metabolomic and machine-learning approaches in labial salivary gland to diagnose primary Sjögren’s syndrome.

79. PTPN22 gene functional polymorphism (rs2476601) in older adults with frailty syndrome.

80. First trimester sCD40L levels associated with adverse neonatal outcomes in euthyroid pregnant women with positive TPOAb.

82. Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome.

83. CVID-Associated B Cell Activating Factor Receptor Variants Change Receptor Oligomerization, Ligand Binding, and Signaling Responses.

84. Induced Overexpression of B Cell-Activating Factor by Triiodothyronine Results in Abnormal B Cell Differentiation in Mice.

85. Deep Insight into the Role of MIF in Spondyloarthritis.

86. Association Among MIF, IFIH1, and IL6 Gene Polymorphisms and Non-Segmental Vitiligo in a Chinese Han Population.

87. TNF-alpha, IL-6, IL-10 and fatty acids in rheumatoid arthritis patients receiving cDMARD and bDMARD therapy.

88. Expression Patterns of Macrophage Migration Inhibitory Factor and Its Gene Variants (MIF-173 G˃C) in Verruca Vulgaris.

89. Potential diagnostic and prognostic of efferocytosis-related unwanted soluble receptors/ligands as new non-invasive biomarkers in disorders: a review.

90. Single-Cell Sequencing of Immune Cell Heterogeneity in IgG4-Related Disease.

91. Sjögren syndrome: looking forward to the future.

92. Binary MoS2 nanostructures as nanocarriers for amplification in multiplexed electrochemical immunosensing: simultaneous determination of B cell activation factor and proliferation-induced signal immunity-related cytokines.

93. Cytokines and chemokines multiplex analysis in patients with low disease activity rheumatoid arthritis.

95. Glycolysis Rate-Limiting Enzymes: Novel Potential Regulators of Rheumatoid Arthritis Pathogenesis.

96. Efficient removal of 2,6-xylidine precipitate using different agitation protocols: An in vitro field emission scanning electron microscopic study.

98. Levels of the macrophage migration inhibitory factor and polymorphisms in systemic lupus erythematosus: a meta-analysis.

99. The influence of periapical lesions on the repeatability of two electronic apex locators in vivo.

100. PADI2 Polymorphisms Are Significantly Associated With Rheumatoid Arthritis, Autoantibodies Serologic Status and Joint Damage in Women from Southern Mexico.

Catalog

Books, media, physical & digital resources